Centene Corp (LTS:0HVB)
$ 60.79 0.79 (1.33%) Market Cap: 30.71 Bil Enterprise Value: 30.85 Bil PE Ratio: 10.60 PB Ratio: 1.15 GF Score: 85/100

Centene Corp at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 01:00PM GMT
Release Date Price: $85.48 (+1.86%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Next session will be with Centene. By the way, I'm Steven Valiquette, the health care services analyst here at Barclays. So welcome again, everybody, to day 1 of the conference. So with us from the company, we have Drew Asher, the CFO, and also Sarah London, Vice Chair.

This will be a fireside chat, but I think Sarah wants to make some comments upfront. So I'll turn it to you.

Sarah M. London
Centene Corporation - Vice Chairman

Great. Thanks, Steve. Thanks for having us. Great to see everyone in 3 dimension. I thought I might just give a quick update as a level set and then turn it back over to you for questions.

So as we said, Centene came into 2022 with strong momentum, thanks to good performance in the Medicare marketplace open enrollment periods, and that's really lined us up nicely against our membership targets. And then in the last 2 months, we've received RFP awards in Indiana and Louisiana, which I think speak to the differentiated value that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot